Sorting It Out: What JNC 8 Is and What It Is Not

The landscape for hypertension guideline development and dissemination has changed. The intense debate surrounding the recent JNC 8 publication obscures the value this guideline offers to providers managing hypertension. Recommendations published by the panel appointed to JNC 8, when interpreted and...

Descripción completa

Detalles Bibliográficos
Autores principales: Finks, Shannon, Ripley, Toni L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2015
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397976/
https://www.ncbi.nlm.nih.gov/pubmed/25614999
http://dx.doi.org/10.18553/jmcp.2015.21.2.110
_version_ 1785083993073385472
author Finks, Shannon
Ripley, Toni L.
author_facet Finks, Shannon
Ripley, Toni L.
author_sort Finks, Shannon
collection PubMed
description The landscape for hypertension guideline development and dissemination has changed. The intense debate surrounding the recent JNC 8 publication obscures the value this guideline offers to providers managing hypertension. Recommendations published by the panel appointed to JNC 8, when interpreted and applied as intended, can indeed guide hypertension management. The purpose of this commentary is to pare down what the JNC 8 publication is and what is not, so as to transcend the controversy and foster application of these guidelines to clinical practice.
format Online
Article
Text
id pubmed-10397976
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103979762023-08-04 Sorting It Out: What JNC 8 Is and What It Is Not Finks, Shannon Ripley, Toni L. J Manag Care Spec Pharm Commentary The landscape for hypertension guideline development and dissemination has changed. The intense debate surrounding the recent JNC 8 publication obscures the value this guideline offers to providers managing hypertension. Recommendations published by the panel appointed to JNC 8, when interpreted and applied as intended, can indeed guide hypertension management. The purpose of this commentary is to pare down what the JNC 8 publication is and what is not, so as to transcend the controversy and foster application of these guidelines to clinical practice. Academy of Managed Care Pharmacy 2015-02 /pmc/articles/PMC10397976/ /pubmed/25614999 http://dx.doi.org/10.18553/jmcp.2015.21.2.110 Text en © 2016, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Commentary
Finks, Shannon
Ripley, Toni L.
Sorting It Out: What JNC 8 Is and What It Is Not
title Sorting It Out: What JNC 8 Is and What It Is Not
title_full Sorting It Out: What JNC 8 Is and What It Is Not
title_fullStr Sorting It Out: What JNC 8 Is and What It Is Not
title_full_unstemmed Sorting It Out: What JNC 8 Is and What It Is Not
title_short Sorting It Out: What JNC 8 Is and What It Is Not
title_sort sorting it out: what jnc 8 is and what it is not
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397976/
https://www.ncbi.nlm.nih.gov/pubmed/25614999
http://dx.doi.org/10.18553/jmcp.2015.21.2.110
work_keys_str_mv AT finksshannon sortingitoutwhatjnc8isandwhatitisnot
AT ripleytonil sortingitoutwhatjnc8isandwhatitisnot

Ejemplares similares